STOCK TITAN

Prestige Consumer (NYSE: PBH) CEO has shares withheld for taxes

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. Chief Executive Officer Ronald M. Lombardi reported a routine tax-related share disposition. On May 2, 2026, 2,665 shares of common stock were withheld at $55.09 per share to cover tax obligations, a non‑market transaction. Following this event, Lombardi directly holds 343,864 shares of Prestige Consumer Healthcare common stock.

Positive

  • None.

Negative

  • None.
Insider Lombardi Ronald M.
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Price or Tax Liability Common Stock, par value $0.01 per share 2,665 $55.09 $147K
Holdings After Transaction: Common Stock, par value $0.01 per share — 343,864 shares (Direct)
Tax-withheld shares 2,665 shares Withheld on May 2, 2026 for tax obligations
Tax-withholding price $55.09 per share Value assigned to the 2,665 withheld shares
Shares held after transaction 343,864 shares Direct PBH common stock holdings after tax withholding
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Common Stock, par value $0.01 per share financial
"security_title: "Common Stock, par value $0.01 per share""
transaction code "F" financial
"transaction_code_description: "Payment of exercise price or tax liability by delivering securities""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did PBH CEO Ronald Lombardi report?

Ronald M. Lombardi reported a tax-withholding disposition of 2,665 Prestige Consumer Healthcare shares. The shares were withheld by the company to cover tax obligations, not sold on the open market, and are recorded at $55.09 per share.

Did the PBH CEO sell shares in the open market in this Form 4?

No. The Form 4 shows a tax-withholding disposition coded “F,” meaning shares were withheld to pay taxes. This is a common administrative event for equity compensation, not an open-market sale initiated by the CEO.

How many Prestige Consumer Healthcare shares does the CEO hold after this filing?

After the tax-withholding transaction, CEO Ronald M. Lombardi directly holds 343,864 shares of Prestige Consumer Healthcare common stock. This figure reflects his position immediately following the 2,665-share withholding for tax obligations disclosed in the Form 4.

What does transaction code “F” mean in the PBH Form 4 filing?

Transaction code “F” indicates payment of an exercise price or tax liability by delivering or withholding securities. In this PBH filing, it reflects 2,665 shares withheld at $55.09 per share to satisfy tax obligations tied to equity compensation.

Is the PBH CEO’s Form 4 transaction considered a buy or sell?

The transaction is classified as a disposition for tax withholding, not a buy or typical sale. Shares were withheld to cover tax liabilities associated with equity awards, so it does not represent an open-market decision to sell stock.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lombardi Ronald M.

(Last)(First)(Middle)
660 WHITE PLAINS ROAD

(Street)
TARRYTOWN NEW YORK 10591

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share05/02/2026F2,665D$55.09343,864D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Ronald M. Lombardi by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 8, 2017 on file with the Commission05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)